Risks of site-specific cancer mortality according to thirds of muscular strength, Aerobics Center Longitudinal Study, 1980-2003
| Anatomic site-strength thirds | Deaths | HR (95% CI)* | ||
|---|---|---|---|---|
| All digestive system† | ||||
| Low | 35 | 1.00 | ||
| Middle | 13 | 0.37 (0.19-0.70) | ||
| High | 17 | 0.49 (0.27-0.87) | ||
| P for linear trend | 0.007 | |||
| Colorectal | ||||
| Low | 11 | 1.00 | ||
| Middle | 2 | 0.18 (0.04-0.82) | ||
| High | 6 | 0.53 (0.20-1.45) | ||
| P for linear trend | 0.16 | |||
| Pancreas | ||||
| Low | 11 | 1.00 | ||
| Middle | 4 | 0.36 (0.11-1.13) | ||
| High | 6 | 0.54 (0.20-1.47) | ||
| P for linear trend | 0.18 | |||
| Lung | ||||
| Low | 17 | 1.00 | ||
| Middle | 17 | 0.998 (0.51-1.96) | ||
| High | 13 | 0.76 (0.37-1.57) | ||
| P for linear trend | 0.47 | |||
| Prostate | ||||
| Low | 3 | 1.00 | ||
| Middle | 7 | 2.56 (0.66-9.97) | ||
| High | 3 | 1.03 (0.21-5.16) | ||
| P for linear trend | 0.96 | |||
| Hematopoietic/lymph | ||||
| Low | 11 | 1.00 | ||
| Middle | 8 | 0.71 (0.28-1.76) | ||
| High | 8 | 0.71 (0.28-1.76) | ||
| P for linear trend | 0.45 | |||